Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS
NCT02048072
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis
Autonomic Nervous System Dysfunction
Interventions
DRUG:
Gilenya
Sponsor
Jochen Vehoff